ClinicalTrials.govpublic full text
A Study of the Efficacy and Safety of Frespaciguat (MK-5475) in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007)
pulmonary arterial hypertension, hypertension, pulmonary
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 238218
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.